Henry Schein to buy 60% of BioHorizons

Henry Schein said Tuesday it has agreed to buy a 60 percent stake in BioHorizons. Financial terms were not disclosed. Henry Schein said it will lend approximately $145 million to BioHorizons to fund, among other uses, a distribution to shareholders, which will occur before the deal closes. Then, Schien will provide an equity investment. Birmingham, Ala.-BioHorizons makes advanced dental implants sold internationally. BioHorizons is a portfolio company of Healthpoint Capital.

DealsNorth AmericaUSBriefs